Acute Respiratory Distress Syndrome clinical trials at UCLA
1 research study open to eligible people
open to eligible people ages 18 years and up
This study seeks to define the ultrasound profile of patients with COVID-19, and document the progression of these ultrasound findings to develop prognostication and clinical decision instruments that can help guide management of patient with COVID-19. Primary aims include the development of ARDS, refractory hypoxemia, acute cardiac injury, pulmonary embolism, pneumothorax or death. Secondary aims include potential change in CT and plain film utilization given the use of POCUS, as well as emergency department and inpatient LOS (length of stay).
Los Angeles, California and other locations
Our lead scientists for Acute Respiratory Distress Syndrome research studies include George Lim, MD.